Spirulina for Heart Health: What the Research Says About Cholesterol and Blood Pressure

Disclaimer: This article is for informational purposes only and is not medical advice. Always consult your healthcare provider before starting any supplement, especially if you take prescription medications.

Table of Contents

1. Why This Matters: Heart Disease by the Numbers
2. Spirulina and Cholesterol: What the Research Shows
3. Spirulina and Blood Pressure: What the Research Shows
4. How Spirulina Protects Your Cardiovascular System
5. Clinical Evidence at a Glance
6. Dosage, Timing, and Quality
7. Who Benefits Most
8. Frequently Asked Questions
9. The Bottom Line
10. References

Why This Matters: Heart Disease by the Numbers

Cardiovascular disease remains the leading cause of death worldwide, responsible for roughly 17.9 million deaths every year. The two biggest modifiable risk factors are dyslipidemia (abnormal cholesterol and triglycerides) and hypertension (high blood pressure). Together, they silently damage arteries for years before a heart attack or stroke ever occurs.

Statins remain the gold standard for cholesterol management, and antihypertensive drugs are well-proven. But many people experience side effects from statins — muscle pain affects up to 29% of users — and others want evidence-based nutritional strategies to complement their treatment plan. This is where spirulina enters the picture.

Over the past decade, a growing body of clinical trials and meta-analyses has demonstrated that spirulina produces statistically significant improvements in LDL cholesterol, total cholesterol, triglycerides, HDL cholesterol, and blood pressure. This isn’t preliminary cell-culture data — these are human studies, pooled across hundreds and in some cases thousands of participants, with results published in peer-reviewed cardiology and pharmacology journals.

This article breaks down the evidence, explains the mechanisms, and tells you exactly what dosages the research supports. For a complete overview of all spirulina benefits, see Spirulina Benefits: The Complete Guide.

Spirulina and Cholesterol: What the Research Shows

The Meta-Analysis Evidence

The strongest evidence for spirulina’s cholesterol-lowering effects comes from multiple meta-analyses — studies that pool data from many individual clinical trials to reach more reliable conclusions.

Rahnama et al. (2023) published a GRADE-assessed systematic review and dose-response meta-analysis in Pharmacological Research, pooling 20 randomized controlled trials with 1,076 participants. The results were clear across all four lipid markers:

Lipid Marker	Effect	Statistical Significance
LDL Cholesterol	Significantly reduced	P < 0.05
Total Cholesterol	Significantly reduced	P < 0.05
Triglycerides	Significantly reduced	P < 0.05
HDL Cholesterol (“good”)	Significantly increased	P < 0.05

This is the complete lipid picture — spirulina improved every measurable cholesterol and lipid marker in the right direction.

How Much Does Spirulina Lower Cholesterol?

The most precise numbers come from Huang et al. (2018), who published a meta-analysis of 12 trials with 14 study arms in Diabetes, Metabolic Syndrome and Obesity. Their pooled results showed:

Marker	Reduction (mg/dL)	P Value
Total Cholesterol	-36.60 mg/dL	P = 0.0001
LDL Cholesterol	-33.16 mg/dL	P = 0.0002
Triglycerides	-39.20 mg/dL	P = 0.0001
VLDL Cholesterol	-8.02 mg/dL	P = 0.0001

To put these numbers in context: a 33 mg/dL reduction in LDL cholesterol is clinically meaningful. Dietary interventions typically achieve 5–15 mg/dL reductions, and some pharmaceutical interventions start in a similar range. Spirulina’s effect on triglycerides — a nearly 40 mg/dL drop — is particularly noteworthy, as triglycerides are often harder to control with diet alone.

How Does Spirulina Compare to Other Natural Supplements?

A landmark 2022 network meta-analysis by Osadnik et al. in Pharmacological Research compared 10 lipid-lowering nutraceuticals across 131 randomized trials enrolling 13,062 participants — one of the largest comparative analyses of its kind. Among the supplements tested (artichoke, berberine, bergamot, garlic, green tea, plant sterols, policosanols, red yeast rice, silymarin, and spirulina), all except policosanols significantly lowered LDL cholesterol compared to placebo. Bergamot and red yeast rice showed the largest effects, while spirulina demonstrated consistent, significant improvements across multiple lipid markers.

What makes spirulina stand out in this comparison isn’t just its cholesterol-lowering effect — it’s the breadth of cardiovascular benefits. Unlike most nutraceuticals that target only lipids, spirulina simultaneously improves cholesterol, triglycerides, blood pressure, blood sugar, and oxidative stress markers. No other supplement in the comparison offered this range of cardiovascular protection.

Key Clinical Trials

Torres-Durán et al. (2007) studied 36 subjects taking 4.5 g of spirulina daily for 6 weeks. Triglycerides dropped from 233.7 to 167.7 mg/dL (P < 0.001), total cholesterol fell from 181.7 to 163.5 mg/dL (P < 0.001), and HDL cholesterol rose from 43.5 to 50.0 mg/dL (P < 0.01). The LDL cholesterol reduction occurred independently of triglyceride changes — suggesting spirulina affects LDL through a separate mechanism, not just as a secondary effect of triglyceride reduction.

Koite et al. (2022) tested a spirulina liquid extract in 40 subjects with metabolic syndrome in a randomized, double-blind trial for 12 weeks. The spirulina group showed significant decreases in plasma triglycerides (P = 0.003) and significant increases in HDL cholesterol (P = 0.031) at all visits. The study also measured oxidized LDL and urinary isoprostanes (markers of oxidative damage), finding that spirulina significantly reduced isoprostanes — indicating it wasn’t just improving cholesterol numbers but reducing the oxidative damage that makes cholesterol dangerous in the first place.

Spirulina and Cholesterol in Type 2 Diabetes

People with type 2 diabetes face dramatically elevated cardiovascular risk, and their lipid profiles are often resistant to dietary interventions. A 2021 meta-analysis by Hatami et al. focused specifically on spirulina in type 2 diabetes patients, pooling 8 studies. The results showed significant reductions in triglycerides (-30.99 mg/dL), total cholesterol (-18.47 mg/dL), LDL cholesterol (-20.04 mg/dL), and VLDL cholesterol (-6.96 mg/dL), along with a significant increase in HDL cholesterol. For the full breakdown of spirulina’s blood sugar mechanisms, see Spirulina vs. Berberine for Blood Sugar.

Spirulina and Blood Pressure: What the Research Shows

The Meta-Analysis Evidence

Three independent meta-analyses have now confirmed spirulina’s blood pressure-lowering effects, each using different inclusion criteria and statistical methods — and all reaching the same conclusion.

Shiri et al. (2024) published the most recent and comprehensive GRADE-assessed meta-analysis in Phytotherapy Research, analyzing all available randomized controlled trials through April 2024. Their pooled results showed spirulina reduces systolic blood pressure by -4.41 mmHg (95% CI: -6.74 to -2.07) and diastolic blood pressure by -2.84 mmHg (95% CI: -4.65 to -1.03). These effects were strongest in specific populations:

Subgroup	SBP Change	DBP Change
Hypertensive individuals (≥120/80)	Significant reduction	Significant reduction
Overweight individuals	Significant reduction	Significant reduction
Age > 50 years	Significant reduction	Significant reduction
Intervention > 8 weeks	Significant reduction	Significant reduction

Machowiec et al. (2021) published an earlier meta-analysis in Nutrients with 5 RCTs and 230 subjects, finding even larger effect sizes: SBP reduced by -4.59 mmHg and DBP reduced by -7.02 mmHg, with particularly strong effects in hypertensive patients.

The most striking finding came from Casas-Agustench et al. (2025), who published a meta-analysis in the Journal of Human Nutrition and Dietetics comparing all edible algae for blood pressure effects. Across 29 RCTs with 1,583 participants, spirulina was the most effective algae tested, reducing systolic blood pressure by -5.28 mmHg (P = 0.032) and diastolic pressure by -3.56 mmHg (P = 0.044). Dosages above 3 g/day and intervention periods of at least 12 weeks showed the greatest benefits.

Why a 5 mmHg Reduction Matters

A 5 mmHg reduction in systolic blood pressure doesn’t sound dramatic — until you understand the epidemiology. Population-level data consistently shows that a sustained 5 mmHg reduction in systolic blood pressure reduces the risk of major cardiovascular events by approximately 10%, stroke risk by 13%, and heart failure risk by 13%. These are the same magnitudes that justify prescribing blood pressure medications. For a supplement with essentially no side effects in healthy adults, that’s a remarkable risk-benefit ratio.

Key Clinical Trials

Miczke et al. (2016) conducted a double-blind, placebo-controlled trial with 40 overweight hypertensive patients taking just 2 g of spirulina daily for 3 months. The spirulina group showed significant reductions in systolic blood pressure (149 to 143 mmHg, P = 0.0023), body weight (75.5 to 70.5 kg, P < 0.001), and — critically — arterial stiffness index (7.2 to 6.9 m/s, P < 0.001). Arterial stiffness is an independent predictor of cardiovascular events, and reducing it means the blood vessels are physically becoming more flexible and healthy.

Martínez-Sámano et al. (2018) investigated the mechanisms behind spirulina’s blood pressure effects in a clinical trial with 16 hypertensive patients already taking ACE inhibitor medications. After 12 weeks of 4.5 g spirulina daily (added to their existing medication), patients showed significant reductions in systolic blood pressure plus decreases in three markers of endothelial damage: sVCAM-1, sE-selectin, and endothelin-1. This is the first clinical trial to demonstrate that spirulina doesn’t just lower the blood pressure number — it reduces the cellular damage happening inside blood vessel walls.

Ghaem Far et al. (2021) took a unique approach: a triple-blind RCT using spirulina-fortified salad dressing (containing 2 g spirulina) in 48 hypertensive patients for 8 weeks. Even at this modest dose delivered through food rather than supplements, the spirulina group showed significant reductions in both systolic (P = 0.02) and diastolic blood pressure (P = 0.03), plus improvements in triglycerides, total cholesterol, and LDL. This trial matters because it shows spirulina works even when incorporated into food at relatively low doses.

How Spirulina Protects Your Cardiovascular System

Spirulina doesn’t work through a single mechanism — it targets multiple cardiovascular risk pathways simultaneously. This multi-target approach is why it improves cholesterol, blood pressure, and vascular health at the same time. Understanding the mechanisms helps explain why the clinical results are so consistent.

ACE Inhibition and Nitric Oxide

Spirulina’s phycocyanin — the blue pigment responsible for most of its biological activity — inhibits angiotensin-converting enzyme (ACE). This is the same enzyme targeted by prescription ACE inhibitors like lisinopril and enalapril. By inhibiting ACE, phycocyanin reduces the production of angiotensin II, a potent vasoconstrictor, and preserves bradykinin, which stimulates nitric oxide production. The result: blood vessels relax and widen, reducing blood pressure.

Research by Ichimura et al. (2013) demonstrated that phycocyanin enhances endothelial nitric oxide synthase (eNOS) expression in the aorta of metabolic syndrome model rats, and that this effect is linked to increased adiponectin levels — a hormone that protects against atherosclerosis. This provides a mechanistic explanation for the blood pressure reductions seen in human trials. For a deep dive into phycocyanin’s biological activities, see Blue Spirulina Benefits: What Phycocyanin Does for Your Body.

Anti-Inflammatory Pathways

Chronic inflammation is now recognized as a central driver of atherosclerosis — the buildup of plaque in arteries that leads to heart attacks and strokes. Spirulina’s phycocyanin is a selective COX-2 inhibitor (Shih et al., 2009) that reduces inflammatory mediators including TNF-alpha, prostaglandin E2, and inducible nitric oxide synthase (iNOS). The comprehensive review by Wu et al. (2016) in Archives of Toxicology detailed how spirulina modulates the NF-κB, ERK1/2, JNK, and p38 signaling pathways — the same pathways targeted by anti-inflammatory pharmaceuticals.

What makes this relevant to heart health specifically: inflammation damages the endothelium (the inner lining of blood vessels), making it easier for LDL cholesterol to penetrate the vessel wall and form plaques. By reducing inflammation, spirulina helps keep the endothelium intact — addressing the root cause rather than just the cholesterol numbers.

Antioxidant Protection Against LDL Oxidation

LDL cholesterol itself isn’t inherently dangerous — it becomes dangerous when it’s oxidized. Oxidized LDL (oxLDL) triggers macrophages in the blood vessel wall to form foam cells, which are the building blocks of atherosclerotic plaques. Spirulina combats this through multiple antioxidant mechanisms.

Wu et al. (2016) documented that spirulina activates cellular antioxidant enzymes (superoxide dismutase, catalase, glutathione peroxidase), inhibits lipid peroxidation and DNA damage, and scavenges free radicals through Nrf2 pathway activation. The clinical trial by Martínez-Sámano et al. (2018) confirmed these mechanisms in humans, showing that spirulina significantly increased glutathione peroxidase activity in hypertensive patients.

Koite et al. (2022) specifically measured oxidized LDL and urinary isoprostanes — gold-standard markers of oxidative damage — and found spirulina significantly reduced isoprostanes in metabolic syndrome patients. This means spirulina doesn’t just lower cholesterol levels; it reduces the oxidative modification that makes cholesterol atherogenic (plaque-forming) in the first place.

Endothelial Protection

The clinical trial by Martínez-Sámano et al. (2018) is particularly important because it measured direct markers of endothelial damage. Spirulina significantly reduced three key biomarkers:

Biomarker	What It Measures	Effect
sVCAM-1	Vascular cell adhesion — how easily immune cells stick to vessel walls	Significantly decreased
sE-selectin	Endothelial activation — how inflamed the blood vessel lining is	Significantly decreased
Endothelin-1	Vasoconstriction — how much the blood vessels are tightening	Significantly decreased

Elevated levels of these markers predict future cardiovascular events even in people with normal cholesterol and blood pressure. By reducing them, spirulina appears to protect the vascular endothelium at a cellular level — not just treating numbers on a lab report.

Lipid Metabolism

Spirulina’s cholesterol-lowering effects likely involve multiple metabolic pathways. Its high gamma-linolenic acid (GLA) content may reduce hepatic cholesterol synthesis. The fiber and phycocyanin content may increase bile acid excretion, forcing the liver to pull cholesterol from the bloodstream to make more bile acids. And spirulina’s documented effects on AMPK pathway activation may enhance cellular fatty acid oxidation, helping the body burn triglycerides more efficiently rather than storing them.

Clinical Evidence at a Glance

Study	Type	Key Finding
Rahnama et al. (2023)	Meta-analysis, 20 RCTs, 1,076 participants	Spirulina significantly reduced LDL, TC, TG and increased HDL
Huang et al. (2018)	Meta-analysis, 12 trials	TC -36.6 mg/dL, LDL -33.2 mg/dL, TG -39.2 mg/dL, DBP -7.17 mmHg
Shiri et al. (2024)	GRADE meta-analysis on BP	SBP -4.41 mmHg, DBP -2.84 mmHg; strongest in hypertensive, overweight, age > 50
Casas-Agustench et al. (2025)	Meta-analysis, 29 RCTs, 1,583 participants	Spirulina most effective algae for BP: SBP -5.28 mmHg, DBP -3.56 mmHg
Machowiec et al. (2021)	Meta-analysis, 5 RCTs, 230 subjects	SBP -4.59 mmHg, DBP -7.02 mmHg
Fu et al. (2025)	Meta-analysis, 23 studies, 1,035 participants	Reduced TC, TG, LDL, DBP; increased HDL. Exercise combo further improved lipids
Osadnik et al. (2022)	Network meta-analysis, 131 trials, 13,062 participants	Spirulina among effective nutraceuticals for LDL and TC lowering
Miczke et al. (2016)	Double-blind RCT, 40 patients, 3 months	2 g/day reduced SBP, weight, BMI, and arterial stiffness
Martínez-Sámano et al. (2018)	RCT, 16 hypertensive patients on ACE inhibitors	4.5 g/day reduced SBP, endothelial damage markers (sVCAM-1, sE-selectin, endothelin-1)
Torres-Durán et al. (2007)	Clinical trial, 36 subjects, 6 weeks	4.5 g/day: TG -66 mg/dL, TC -18.2 mg/dL, HDL +6.5 mg/dL, reduced SBP and DBP
Ghaem Far et al. (2021)	Triple-blind RCT, 48 hypertensive patients	2 g/day in food reduced SBP, DBP, TG, TC, and LDL

Dosage, Timing, and Quality

What Dosage Do the Studies Support?

The clinical trials showing cardiovascular benefits used dosages ranging from 1 to 8 grams per day, with most positive results clustered at 2–4.5 grams daily. Based on the available evidence:

Goal	Suggested Dose	Duration
General cardiovascular support	2–3 g/day	Ongoing
Cholesterol reduction	3–4.5 g/day	8–12 weeks minimum
Blood pressure reduction	2–4.5 g/day	8+ weeks (Shiri et al. subgroup)
Comprehensive lipid + BP improvement	4–5 g/day	12+ weeks

Benefits increase with longer duration. The 2025 meta-analysis by Casas-Agustench et al. found the most significant blood pressure effects with interventions lasting 12 weeks or more and dosages above 3 g/day.

Timing

Take spirulina in the morning with a cold smoothie, juice, or room-temperature water. Avoid mixing with hot beverages — phycocyanin denatures above 60°C (140°F), destroying the compound responsible for the ACE inhibition, anti-inflammatory, and antioxidant effects that drive the cardiovascular benefits. Separate from coffee or tea by 30–60 minutes to maximize iron absorption. For the full guide to preparation methods, see 10 Easy Methods for Using Spirulina Powder.

Quality Matters More Than You Think

Not all spirulina delivers the same cardiovascular benefits. The active compound driving most of the heart-protective mechanisms — phycocyanin — is extremely heat-sensitive. This is where the processing method becomes critical.

Spray-dried spirulina (the vast majority of products on the market, predominantly imported from China) is processed at 150–200°C. At these temperatures, phycocyanin’s protein structure denatures. You still get the protein and basic minerals, but you lose the ACE inhibition, COX-2 inhibition, NADPH oxidase inhibition, and Nrf2 pathway activation that produce the cardiovascular benefits documented in the research.

Freeze-dried spirulina preserves the full concentration of active phycocyanin because it never uses destructive heat. Royal Spirulina is USA-grown and freeze-dried, preserving 15%+ phycocyanin content — the same bioactive form used in many of the studies cited in this article. For a detailed quality comparison, see Freeze-Dried vs. Spray-Dried Spirulina: Complete Quality Comparison.

Beyond processing, sourcing matters for safety. Spirulina grown in uncontrolled open ponds can be contaminated with heavy metals and microcystins (hepatotoxins from wild algae). For a complete guide to contamination risks and what to look for, see Best Spirulina Powder: Why Freeze-Dried Quality Matters.

Spirulina Plus Exercise: Even Better Results

The 2025 meta-analysis by Fu et al. found that combining spirulina with regular exercise enhanced certain lipid outcomes beyond what either intervention achieved alone. Specifically, the combination further improved HDL cholesterol (effect size 1.08 vs. 0.53 for spirulina alone) and LDL cholesterol (effect size -0.81 vs. -0.71 for spirulina alone). This makes physiological sense — exercise increases HDL cholesterol through its own mechanisms, and spirulina’s antioxidant protection may enhance the cardiovascular adaptations triggered by physical activity. For more on spirulina and exercise, see Spirulina for Athletes: Workout Recovery and Performance.

Who Benefits Most

Based on the subgroup analyses across multiple meta-analyses, these populations show the strongest cardiovascular benefits from spirulina supplementation:

Population	Primary Benefit	Evidence Strength
Adults with elevated cholesterol	LDL, TC, TG reduction	Strong — multiple meta-analyses
Adults with hypertension (≥120/80)	SBP and DBP reduction	Strong — GRADE moderate quality
Overweight/obese adults	Lipids + BP + body weight	Strong — 23-study meta-analysis
Adults with metabolic syndrome	Lipids + oxidative stress reduction	Moderate — multiple RCTs
Type 2 diabetes patients	Lipids + fasting glucose	Moderate — 8-study meta-analysis
Adults age > 50	Blood pressure reduction	Moderate — subgroup analysis
Statin-intolerant patients	Cholesterol management alternative	Emerging — positioned by Osadnik et al.

Important: If you take blood pressure medications, diabetes medications, or blood thinners, spirulina can interact with these drugs. Always consult your doctor before starting spirulina supplementation, and monitor your levels more frequently during the first few weeks. For the complete guide to drug interactions, see What to Avoid When Taking Spirulina (and What Not to Mix It With).

For gender-specific cardiovascular benefits, see Spirulina Benefits for Men and Spirulina Benefits for Women.

Frequently Asked Questions

Can spirulina replace my cholesterol medication?

No — and you should not stop any prescribed medication based on spirulina research. Statins reduce LDL cholesterol by 30–50% and have decades of outcome data proving they prevent heart attacks and strokes. Spirulina’s LDL reductions of 20–33 mg/dL are meaningful but more modest. However, spirulina may be a useful complement to medication, or an option for people with mild elevations who aren’t yet candidates for statins. The network meta-analysis by Osadnik et al. (2022) specifically positioned nutraceuticals like spirulina as options for statin-intolerant patients. Discuss any changes with your doctor.

Can spirulina replace my blood pressure medication?

No. Spirulina’s blood pressure reductions of 4–7 mmHg are clinically significant but usually not enough to replace antihypertensive drugs in people with established hypertension. The Martínez-Sámano et al. (2018) trial showed benefits when spirulina was added to existing ACE inhibitor therapy — suggesting it works well as a complement, not a replacement. Never stop blood pressure medication without your doctor’s guidance.

How long before I see results?

Most clinical trials showing cholesterol improvements used intervention periods of 6–12 weeks. Blood pressure reductions appeared as early as 8 weeks in the Shiri et al. (2024) subgroup analysis. The longest trials (12 weeks) generally showed the strongest effects for both lipids and blood pressure. Plan for at least 8–12 weeks of consistent supplementation before expecting measurable changes on blood work.

Does the form of spirulina matter — powder vs. tablets?

The clinical trials used spirulina in powder, tablets, capsules, and even as a food additive (salad dressing in Ghaem Far et al., 2021). All forms showed benefits. What matters most is the quality and processing method — freeze-dried spirulina preserves the full phycocyanin content that drives the cardiovascular mechanisms. Whether you take it as powder in a smoothie or as tablets is a matter of convenience and preference.

Is spirulina safe if I already have heart disease?

Spirulina has GRAS (Generally Recognized As Safe) status from the FDA, and clinical trials have used it in patients with hypertension, metabolic syndrome, and type 2 diabetes without adverse effects. However, if you have existing heart disease, you are likely on multiple medications. Spirulina can interact with blood thinners (vitamin K content), blood pressure medications (additive hypotension), and diabetes medications (additive blood sugar lowering). Consult your cardiologist before starting spirulina. For the complete drug interaction guide, see What to Avoid When Taking Spirulina.

Can I take spirulina with fish oil for heart health?

Yes — and there may be complementary benefits. Muga and Chao (2014) studied the combination of fish oil and spirulina in a hypercholesterolemic animal model and found that the combination inhibited oxidative stress and inflammation. Fish oil primarily targets triglycerides and has mild anti-inflammatory effects, while spirulina targets LDL, total cholesterol, blood pressure, and oxidative stress through different mechanisms. The combination addresses more cardiovascular risk factors than either supplement alone.

Does spirulina help with atherosclerosis (plaque buildup)?

No human trials have directly measured atherosclerotic plaque regression with spirulina. However, the available evidence strongly supports an anti-atherogenic profile: spirulina lowers LDL cholesterol (the primary driver of plaque formation), reduces LDL oxidation (the process that makes LDL dangerous), decreases endothelial damage markers (the cellular injury that allows plaque to form), and reduces inflammatory mediators (the signals that recruit immune cells into plaques). Whether these mechanistic benefits translate to measurable plaque regression in humans remains to be studied.

What about spirulina and C-reactive protein (CRP)?

CRP is a marker of systemic inflammation and an independent cardiovascular risk factor. Several individual trials have measured CRP, with mixed results — some showing reductions and others showing no change. The Ghaem Far et al. (2021) trial specifically measured hs-CRP and found no significant change with spirulina. Spirulina appears to exert its anti-inflammatory effects more through local pathways (COX-2, endothelial markers) than through systemic CRP reduction. This doesn’t diminish its cardiovascular benefits — it just means CRP may not be the best biomarker to track spirulina’s effects.

The Bottom Line

Cardiovascular Benefit	Typical Effect Size	Evidence Level
LDL cholesterol reduction	-20 to -33 mg/dL	Strong — multiple meta-analyses
Total cholesterol reduction	-18 to -37 mg/dL	Strong — multiple meta-analyses
Triglyceride reduction	-31 to -39 mg/dL	Strong — multiple meta-analyses
HDL cholesterol increase	+5 to +7 mg/dL	Strong — multiple meta-analyses
Systolic BP reduction	-4 to -5 mmHg	Strong — 3 independent meta-analyses
Diastolic BP reduction	-3 to -7 mmHg	Strong — 3 independent meta-analyses
Arterial stiffness reduction	Significant decrease	Moderate — 1 RCT
Endothelial damage reduction	Significant decrease in sVCAM-1, sE-selectin, endothelin-1	Moderate — 1 RCT
Oxidative stress reduction	Reduced isoprostanes and increased antioxidant enzymes	Moderate — multiple RCTs

The cardiovascular evidence for spirulina is now among the strongest in the supplement world — backed by multiple independent meta-analyses, numerous randomized controlled trials, and well-understood biological mechanisms. Spirulina’s unique advantage is that it doesn’t just address one risk factor: it simultaneously improves cholesterol, triglycerides, blood pressure, oxidative stress, and endothelial function through complementary pathways.

It is not a replacement for prescribed cardiovascular medications, but the research supports its use as a complementary strategy — particularly for people with mild-to-moderate cardiovascular risk factors, statin-intolerant patients, and anyone looking for evidence-based nutritional support for heart health.

The most important factor in getting these benefits is quality. Cheap, spray-dried spirulina imported from uncontrolled sources may not deliver the active phycocyanin that drives the mechanisms documented in the research. Royal Spirulina is USA-grown and freeze-dried, preserving the full concentration of heart-protective phycocyanin at 15%+ — the bioactive form that the science supports.

References

1. Rahnama I, Arabi SM, Chambari M, et al. The effect of Spirulina supplementation on lipid profile: GRADE-assessed systematic review and dose-response meta-analysis. Pharmacol Res. 2023;193:106802. PubMed
2. Huang H, Liao D, Pu R, Cui Y. Quantifying the effects of spirulina supplementation on plasma lipid and glucose concentrations, body weight, and blood pressure. Diabetes Metab Syndr Obes. 2018;11:729-742. PubMed
3. Shiri H, Yasbolaghi Sharahi J, Alizadeh Sani M, et al. The effect of spirulina supplementation on blood pressure in adults: a GRADE-assessed systematic review and meta-analysis. Phytother Res. 2024;39(1):397-412. PubMed
4. Machowiec P, Ręka G, Maksymowicz M, Piecewicz-Szczęsna H, Smoleń A. Effect of spirulina supplementation on systolic and diastolic blood pressure: systematic review and meta-analysis. Nutrients. 2021;13(9):3054. PubMed
5. Casas-Agustench P, Míguez S, Brookes Z, Bescos R. Edible algae reduce blood pressure in humans: a systematic review and meta-analysis. J Hum Nutr Diet. 2025;38(4):e70095. PubMed
6. Fu Z, Zhou S, Gu X. Effects of spirulina supplementation alone or with exercise on cardiometabolic health in overweight and obese adults: a systematic review and meta-analysis. Front Nutr. 2025;12:1624982. PubMed
7. Osadnik T, Goławski M, Lewandowski P, et al. A network meta-analysis on the comparative effect of nutraceuticals on lipid profile in adults. Pharmacol Res. 2022;183:106402. PubMed
8. Hatami E, Ghalishourani SS, Najafgholizadeh A, et al. The effect of spirulina on type 2 diabetes: a systematic review and meta-analysis. J Diabetes Metab Disord. 2021;20(1):883-892. PubMed
9. Miczke A, Szulińska M, Hansdorfer-Korzon R, et al. Effects of spirulina consumption on body weight, blood pressure, and endothelial function in overweight hypertensive Caucasians. Eur Rev Med Pharmacol Sci. 2016;20(1):150-156. PubMed
10. Martínez-Sámano J, Torres-Montes de Oca A, Luqueño-Bocardo OI, Torres-Durán PV, Juárez-Oropeza MA. Spirulina maxima decreases endothelial damage and oxidative stress indicators in patients with systemic arterial hypertension. Mar Drugs. 2018;16(12):496. PubMed
11. Torres-Durán PV, Ferreira-Hermosillo A, Juárez-Oropeza MA. Antihyperlipemic and antihypertensive effects of Spirulina maxima in an open sample of Mexican population. Lipids Health Dis. 2007;6:33. PubMed
12. Ghaem Far Z, Babajafari S, Kojuri J, et al. Antihypertensive and antihyperlipemic of spirulina sauce on patients with hypertension: a randomized triple-blind placebo-controlled clinical trial. Phytother Res. 2021;35(11):6181-6190. PubMed
13. Koite NLN, Sanogo NI, Lépine O, Bard JM, Ouguerram K. Antioxidant efficacy of a Spirulina liquid extract on oxidative stress status and metabolic disturbances in subjects with metabolic syndrome. Mar Drugs. 2022;20(7):441. PubMed
14. Wu Q, Liu L, Miron A, Klímová B, Wan D, Kuča K. The antioxidant, immunomodulatory, and anti-inflammatory activities of Spirulina: an overview. Arch Toxicol. 2016;90(8):1817-1840. PubMed
15. Shih CM, Cheng SN, Wong CS, Kuo YL, Chou TC. Antiinflammatory and antihyperalgesic activity of C-phycocyanin. Anesth Analg. 2009;108(4):1303-1310. PubMed
16. Ichimura M, Kato S, Tsuneyama K, et al. Phycocyanin prevents hypertension and low serum adiponectin level in a rat model of metabolic syndrome. Nutr Res. 2013;33(5):397-405. PubMed

Related Reading

Spirulina Benefits: The Complete Guide — Comprehensive overview of all spirulina health benefits.

Blue Spirulina Benefits: What Phycocyanin Does for Your Body — The science behind spirulina’s most powerful compound.

What to Avoid When Taking Spirulina — Drug interactions, foods to avoid, and safety precautions.

Spirulina vs. Berberine for Blood Sugar — DPP-IV inhibition vs. AMPK activation compared.

Spirulina Side Effects: What You Need to Know — Potential side effects and how to manage them.

Spirulina Benefits for Men — Testosterone, heart, prostate, and performance benefits.

Spirulina Benefits for Women — Iron, hormones, pregnancy considerations, and more.

Spirulina for Athletes: Workout Recovery and Performance — Exercise performance and cardiovascular adaptations.

Spirulina Protein: The Complete Guide — 60–70% complete protein, amino acid profile, and digestibility.

Best Spirulina Powder: Why Freeze-Dried Quality Matters — How to choose safe, high-quality spirulina.

Spirulina for Eye Health: Zeaxanthin, Macular Degeneration & Vision — How spirulina’s zeaxanthin and phycocyanin protect your eyes from macular degeneration and blue light damage.

Spirulina for Liver Health: NAFLD, Fatty Liver & Detox — How spirulina protects against fatty liver disease through antioxidant, anti-inflammatory, and metabolic pathways.